These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3277333)

  • 1. [Nitrosomethylurea in the clinical chemotherapy of malignant tumors].
    Dement'eva NP
    Vopr Onkol; 1988; 34(1):8-17. PubMed ID: 3277333
    [No Abstract]   [Full Text] [Related]  

  • 2. [Optimization and prognosis of the effectiveness of using nitrosomethylurea for treating malignant tumor patients based on pharmacokinetic parameters].
    Konradov AA; Kutyrkin VA; Kim VA; Korman DB; Emanuél' NM
    Izv Akad Nauk SSSR Biol; 1985; (1):16-24. PubMed ID: 3980847
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nitrosomethylurea in the treatment of patients with disseminated cutaneous melanoma].
    Dement'eva NP; Koroleva LA
    Vopr Onkol; 1984; 30(7):51-4. PubMed ID: 6464402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nitrosomethylurea -- 30 years of study and use in the treatment of cancer patients].
    Dement'eva NP; Korman DB
    Vopr Onkol; 2001; 47(6):655-61. PubMed ID: 11826484
    [No Abstract]   [Full Text] [Related]  

  • 5. Modern problems of clinical chemotherapy of malignant tumours.
    Perevodchikova NI; Bychkov MB
    Arch Geschwulstforsch; 1980; 50(7):657-63. PubMed ID: 6263209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the efficacy of imidazole-carboxamide and of a combination of nitrosomethylurea, vincristine and dactinomycin in disseminated melanoma].
    Kogoniia LM; Moroz LV; Perevodchikova NI; Platinskiĭ LV; Borisov AI
    Vopr Onkol; 1981; 27(4):16-21. PubMed ID: 7015692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The probability of the carcinogenic risk of using nitrosomethylurea for treating cancer patients].
    Korman DB
    Vopr Onkol; 2000; 46(3):274-7. PubMed ID: 10976271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action of N-nitrosomethylurea on antitumor antibiotic-resistent substrains of Fisher L-5178 lymphadenosis].
    Minenkova EA; Fomina MM; Evseenko LS
    Izv Akad Nauk SSSR Biol; 1980; (1):54-61. PubMed ID: 7358895
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental study of the antitumor activity of nitrosomethylurea, adriablastine and ftorafur on model gliomas with different growth rates].
    Romodanov AP; Zhmareva EN; Butsenko OI
    Zh Vopr Neirokhir Im N N Burdenko; 1983; (4):11-9. PubMed ID: 6414203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hematopoiesis during combined treatment of lung cancer patients with cyclophosphan and nitrosomethylurea or CCNU].
    Sokolova II; Trubnikova EN; Trakhtenberg AKh
    Ter Arkh; 1980; 52(9):88-91. PubMed ID: 7434240
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of nitrosourea derivatives in the treatment of patients with Hodgkin's disease with lesions of the central nervous system].
    Gershanovich ML; Arkhipov AI; Vilenskiĭ BS
    Vopr Onkol; 1988; 34(5):542-9. PubMed ID: 3381494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea.
    Rose DP; Noonan JJ
    Cancer Res; 1982 Jan; 42(1):35-8. PubMed ID: 6797725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cyclophosphamide-nitrosomethylurea-induced changes in rat incisors].
    Reichart P; Althoff J; Rippel W
    Dtsch Zahnarztl Z; 1980 Jan; 35(1):93-5. PubMed ID: 6931740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of N-nitrosomethylurea on substrains of Fisher lymphadenosis L-5178 resistant to antitumoral antibiotics.
    Minenkova EA; Fomina MM; Evseenko LS
    Biol Bull Acad Sci USSR; 1980; 7(1):40-6. PubMed ID: 7437480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical and morphological evidence for the origin of N-nitrosomethylurea-induced and naturally occurring primary lung tumors in F344/NCr rats.
    Ohshima M; Ward JM; Singh G; Katyal SL
    Cancer Res; 1985 Jun; 45(6):2785-92. PubMed ID: 3886137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of nitrosomethylurea in oncologic patients].
    Korman DB; Kim OA; Gor'kov VA
    Vopr Onkol; 1988; 34(6):694-9. PubMed ID: 3394269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aranoza -- a new Russian antineoplastic drug].
    Gorbunova VA; Orel NF; Semina OV; Egorov GN; Borodkina AG; Manziuk LV
    Vopr Onkol; 2001; 47(6):672-5. PubMed ID: 11826486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in the proliferative activity of human breast cancer cells cultivated in vivo in diffusion chambers in response to antineoplastic agents].
    Shamaev VI; Krutova TV; D'iachkovskaia RF; Korman DB
    Biull Eksp Biol Med; 1981 Jul; 92(7):77-9. PubMed ID: 6794665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of nitrosomethylurea in the chemotherapy of small cell cancer of the lung].
    Borisov VI; Dement'eva NP
    Sov Med; 1984; (12):47-50. PubMed ID: 6098026
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of effect of indomethacin on the growth of N-nitrosomethylurea-induced rat mammary tumors.
    Pérez-López FR; Lorenzo HK; Urcia MA; Hergueta J; Lafarga L; Guillen V
    Rev Esp Oncol; 1985; 32(1):15-21. PubMed ID: 3843001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.